Monographie - Oseltamivir - Stabilis 4.0

Seneste opdatering :
21/01/2026

Antiviral

Oseltamivir

Oral opløsning

Stabilitet af farmaceutiske tilberedninger

Stabilitet i blandinger

Faktorer der påvirker stabiliteten

Kompatibilitet

Bibliografi

pdf

Kemisk struktur

Oral opløsning

Bibliografi

Oral opløsning

Bibliografi : Oseltamivir

	Type	offentliggørelse
2692	Journal	Winiarski AP, Infeld MH, Tscherne R, Bachinsky M, Rucki R, Nagano-Mate K. Preparation and stability of extemporaneous oral liquid formulations of oseltamivir using commercially available capsules. J Am Pharm Assoc 2007 ; 47, 6; 747-755.
3090	Journal	Voudrie MA, Brett Allen D. Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution). Int J Pharm Compound 2010 ; 14, 1: 82-85.
3996	Journal	Dijkers E,Nanhekhan V,Thorissen A. Updated Stability Data of Midazolam, Oseltamivir Phosphate, and Propranolol Hydrochloride in SyrSprend SF and Minoxidil in Espumil. Int J Pharm Compound 2017 ; 21,3 : 240-241.
4177	Journal	Polonini H, Loures da Silva S, Fernandes Brandao M.A, Bauters T, De Moerloose B, De Oliveira Ferreira A. Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF PH4. Int J Pharm Compound 2018 ;22,6:516-526

Mentions Légales